First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Strategic partnership to revolutionize urine testing August 28, 2024 Daily internet use supercharges your memory! October 24, 2024 Omega-3 fatty acids found to significantly reduce acne in new study July 15, 2024